Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Donaldson

Adult Reconstructive Orthopaedic Surgery Colton, CA Medical Doctor

NPI 1457315269 CMS profile 518513

900 E Washington St, #200, Colton, CA 92324

Open in the dashboard

General payments

$892,843

199 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Donaldson of Colton, CA is reported in the CMS Open Payments database as having received $892,843 across 199 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $74,676 11
2024 General $20,229 14
2023 General $35,810 35
2022 General $105,611 51
2021 General $164,596 19
2020 General $207,832 20
2019 General $284,089 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Donaldson
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Thomas Donaldson were reported at $74,676. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Thomas Donaldson Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $284,089 $1,416 $292–$9,336 $163
2020 $207,832 $647 $141–$6,474 $114
2021 $164,596 $1,073 $211–$6,497 $132
2022 $105,611 $1,217 $236–$6,299 $149
2023 $35,810 $1,082 $246–$6,818 $160
2024 $20,229 $1,575 $323–$8,944 $164
2025 $74,676 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $810,180 160 payments
  2. Kyocera Medical Technologies, Inc. $72,592 5 payments
  3. Exactech, Inc. $8,564 13 payments
  4. Medacta USA, Inc. $915 11 payments
  5. Ossur Americas., Inc $261 3 payments
  6. Bodycad USA Corp $153 1 payment
  7. Stryker Corporation $94 2 payments
  8. Medtronic, Inc. $23 1 payment
  9. AbbVie, Inc. $22 1 payment
  10. Boston Scientific Corporation $19 1 payment
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $740,463 43 payments
  2. Consulting Fee $128,575 29 payments
  3. Travel and Lodging $18,729 44 payments
  4. Food and Beverage $5,058 82 payments
  5. Education $17 1 payment
Products named General payments · program years 2019–2025
  1. Vanguard Knees $446,578 9 payments
  2. Vanguard Knees $149,824 4 payments
  3. Arcos Hips $37,389 16 payments
  4. Arcos Hips $33,912 11 payments
  5. Vanguard Complete Knee Solution $32,519 2 payments
  6. Arcos Hips $25,021 10 payments
  7. G7 Hips $24,627 19 payments
  8. Arcos Revision Hip Instrumentation $22,510 8 payments
  9. G7 Hips $16,125 11 payments
  10. Arcos Hips $13,925 4 payments
  11. Other $68,535 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

267

Median for Orthopedic Surgery: 203

Drug cost

$4,838

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vancomycin Hcl Generic 19 $4,035
Baclofen Generic 31 $308
Meloxicam Generic 137 $298
Amoxicillin Generic 53 $127
Prednisone Generic 27 $70

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$243,065

Of which drugs: $439

Medicare patients

620

Average age 74

Services billed

1,098

409 women, 211 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Chronic kidney disease 25%
Ischemic heart disease 22%
Depression 22%
Osteoporosis 20%
Cancer 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 20 164 $128

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record